Anne Katrin Werenskiold

Title: Anne Katrin Werenskiold: Innovator in Bone Cell Research

Introduction

Anne Katrin Werenskiold is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biomedical research, particularly in the study of bone cells and breast cancer. With a total of 2 patents, her work focuses on innovative methods for understanding and diagnosing critical health conditions.

Latest Patents

Werenskiold's latest patents include groundbreaking methods for identifying modulators of bone cell proliferation and differentiation. The first patent relates to compositions comprising a compound that modulates the activity of T1-M protein. This invention provides an in vitro method for influencing the proliferation and differentiation potential of bone cells. The second patent is directed towards a method for prognosticating the illness development of patients with carcinoma of the breast. This method involves a qualitative determination of T1 protein and/or T1-mRNA in patient samples, along with kits designed for performing these methods.

Career Highlights

Throughout her career, Anne Katrin Werenskiold has worked with esteemed organizations such as the GSF-Forschungszentrum für Umwelt und Gesundheit, GmbH. Her research has significantly advanced the understanding of bone cell behavior and breast cancer diagnostics.

Collaborations

Werenskiold has collaborated with notable professionals in her field, including Jörg Schmidt. These partnerships have further enriched her research and contributed to her innovative work.

Conclusion

Anne Katrin Werenskiold's contributions to biomedical research exemplify her dedication to advancing health science. Her innovative patents and collaborations highlight her role as a leading inventor in the field.